Large-vessel Vasculitis Affecting the Aorta and its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 31839593.
- Also identified by DOI 10.3899/jrheum.190862.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe the features of large-vessel vasculitis (LVV) as it affects the aorta and its branches in patients with relapsing polychondritis (RP). Retrospective data and systematic literature review. Twenty-one patients were identified. LVV diagnosis was subsequent to RP and associated with extrachondral involvement in the majority of patients. Supraaortic vessels were more frequently involved (82%). Fourteen patients (67%) were treated with a conventional synthetic disease-modifying antirheumatic drug (csDMARD) and 7 (33%) with a biological DMARD (bDMARD). Vascular interventional procedures were performed in 10 patients (48%). Premature death due to cardiovascular complications was reported in 3 cases (14%). Extraaortic LVV is a serious and overlooked RP manifestation. All patients with RP should be investigated for LVV.
Medical subject headings
- Antirheumatic Agents
- Giant Cell Arteritis
- Polychondritis, Relapsing